Our blog features educational information and personal perspectives relevant to the hereditary cancer community.
December 12, 2012
Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road
Posted in:
Research
Tags:
BRCA, Breast Cancer, Hereditary Cancer Research, BRCA1, BRCA2, FDA, Clinical Trials, PARP Inhibitor
Most Recent
Prevent Cancer Dialogue makes an in-person return for 2022 conference
A new tool is helping families conduct life-saving conversations about hereditary cancer
The Tigerlily Foundation: Removing Barriers to Breast Cancer Care for the Black Community
African American Women Need to Know More About High-Risk Breast Cancer
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research, Cancer Treatment
Tags:
BRCA, Ovarian Cancer, Genetic Testing, BRCA1, BRCA2, PALB2, Pancreatic Cancer, ATM, Gene Panel Testing, Metastatic Breast Cancer, Ovarian Cancer Treatment, PARP Inhibitor, Cancer Research, Advanced Breast Cancer, Inherited Mutations, Prostate Cancer Treatment, Metastatic Prostate Cancer, Cancer Targeted Therapy
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.
November 19, 2019
FORCE Launches the New XRAY-Ovarian Cancer Program
Posted in:
XRAY
Tags:
Hereditary Cancer, Ovarian Cancer, PARP Inhibitor, Cancer Research
January 06, 2020
New PARP Inhibitor Approval for Pancreatic Cancer
August 24, 2020
PARP Inhibitor Treatment Is Helping My Pancreatic Cancer
Posted in:
Stories
Tags:
BRCA1, Pancreatic Cancer, PARP Inhibitor, Pancreatic Cancer Treatment, Men With Mutations